QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
When Time Stands Still: TLV´s New Rules for JCA (& more)
The decision timelines for Nordic HTA agencies vary depending on the agency and submission process. In Sweden, Tandvårds- och läkemedelsförmånsverket, TLV—responsible for the reimbursement system of outpatient medicines —has a maximum processing time of 180 days from when a submission is deemed complete.
A recent update, published in January, may affect Sweden’s timelines:
1️⃣ Joint Clinical Assessment(JCA): An application is only deemed complete once the JCA […]
Here´s a fun fact:
Amsterdam’s elevation is -2 meters! The Quantify Research has been training at altitude for this year’s World Evidence, Pricing and Access Congress during 5-6 March in Amsterdam. We’re looking forward to seeing you next week, and it is not too late to book a meeting with the team.
To discuss the […]
Join us for Quantify´s first annual social!
Are you located in Stockholm and working in HEOR, RWE or a similar area in lifescience or biotech? Join us on March 19th at Clarion Hotel® 𝐀𝐦𝐚𝐫𝐚𝐧𝐭𝐞𝐧 for a causual after work mingle with your colleagues and friends.
More information can be here and don’t forget to RSVP! Click here
Only two more weeks!
Quantify Research is gearing up for this year’s World Evidence, Pricing and Access Congress during 5-6 March in Amsterdam.
What are you most looking forward to this time around?
To discuss the latest in evidence, pricing, and access – reach out to Béranger Lueza and Abraham Choong to book a meeting!
[…]